antiviral therapeutics (Goff Hill)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantiviral therapeutics (Goff Hill)
Drug Alias NameESP (Biomolecular Pharma)antiviral compound (Biomolecular Pharma)ESP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsMultiple SclerosisMorbillivirus InfectionsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesGoff Hill Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGoff Hill Ltd
Inactive CompaniesN/A
Active IndicationsMultiple SclerosisMorbillivirus InfectionsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A